China Immunoassay Market PowerPoint PPT Presentations

Immunoassay Market to 2027 - Global Analysis and Forecasts By Product (Reagents & Kits, Analyzers & Instruments, and Software & Services), Technology [Enzyme-Linked Immunosorbent Assays (ELISA), Fluorescence, Chemiluminescence, Rapid Test, Western Blot, Enzyme-Linked Immune Absorbent Spot (ELISPOT), and Polymerase Chain Reaction (PCR)], Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), and End User (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others)

China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026. Forecast by Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, Point of Care Testing, Coagulation), Company Analysis.

iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China%20IVD%20Market%20and%20Forecast%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

This report studies Drug Screening in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Quest Alere Roche Thermo Fisher Dr?gerwerk Siemens Express Shimadzu

An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes).

The improvement in food safety regulations, rapid advancement in automation of food testing protocols, increasing occurrence of food borne illness, growing demand of the packaged and organic food products will accelerate the growth of molecular methods market in the forecast period of 2020-2027.. On the other hand, rise in the cost of advanced molecular testing equipment and lack of food safety awareness in emerging economies will hamper the growth of the market in the above mentioned forecast period.

Data Bridge Market Research analyses that the enzyme immunoassay (EIA) reagents and devices market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.

Rising prevalence of chronic and infectious diseases coupled with rising geriatric population are the major reasons attributable to the growth of enzyme immunoassay (EIA) reagents and devices market. Data Bridge Market Research analyses that the enzyme immunoassay (EIA) reagents and devices market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.

China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets.

Some of the common tests that are available with today’s physicians are skin-prick testing, intradermal testing, and oral for confirmatory allergy testing. These tests are critical where the history describes serious allergic reactions; risk assessments based on historical descriptions alone are not reliable. Most of these tests are usually performed under specialized hands in speciality clinics, because, positive test results are less likely to be determined as the time period increases.

iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China%20IVD%20Market%20and%20Forecast%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

Global Fluorescence Polarization Immunoassay Analyzer Market Research Report 2017

The worldwide smartphone market continues to grow and the Chinese market has remained the major driving force behind. Development Trends of Smartphone Panels in China Report analyzes the development of panels for Chinese smartphones from the perspectives of end product brands and the product itself. See Full Report: http://bit.ly/1NaVerb

iGATE Research has released a research report on “Food Safety Testing Market (by Contaminants, Pathogens, Type of Food Tested, Technology/Method, Region & Company Profile) and Forecast – Global Analysis to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=146 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025. The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

Get more details @ http://bit.ly/2sK8r9n Some of the prominent Automated Immunoassay Analyzers industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.

The global D-dimer testing market size was valued at US$ 1.23 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing is driving the global D-dimers market.The D-dimer test is used to find out if the patient is suffering from blood clotting disorder. The clotting of blood is very important, if the blood is not clotted, it may ooze out and the patient suffers from heavy blood loss.

Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine.

Big Market Research | Noninvasive Cancer Diagnostics and Technologies Market | Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013.

iGATE Research has released a research report on “China In-Vitro Diagnostics (IVD) Market, Size, Share, Trends, Regulations, Reimbursement & Key Players Analysis - Forecast to 2026” Click here to view the complete report: https://www.igateresearch.com/china-in-vitro-diagnostics-ivd-market-size-share-trends-regulations-reimbursement-key-players-analysis-forecast-to-2026.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017.

To Get sample Brochure now@ http://tinyurl.com/z5hlh4y A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Food Diagnostic Equipment and Consumables Market and future opportunities are provided in the report.

Food Testing Market shall witness 8.4% CAGR growth until 2018 owing to the increased number of tests that will be conducted. According to IndustryARC, Food Testing Market which includes the food safety testing market is expected to grow at a healthy growth rate of around 6% during the forecast period until 2018.

In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. Check complete report @ http://www.marketintelreports.com/report/allied0076/in-vitro-diagnostics-ivd-asiapacific-market--opportunities-and-forecasts-2014--2020

Radio immunoassay (RIA) reagents and devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 3.52% in the above-mentioned forecast period.

The report on Womens Health Market by treatment type (hormonal, non-hormonal), diseases indication (hypothyroidism, osteoporosis, uterine fibroid, cancer, post-menopausal syndrome, contraceptive, urinary tract infection), distribution channel (online, hospital, retail pharmacy) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Womens Health Market is projected to grow at a CAGR of 5.72% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

Fluorescence immunoassay analyzers are immunofluorescence based diagnostics systems which involve in-vitro biochemical test used for rapid detection of antigens or antibodies in a sample. Modern fluorescence immunoassay analyzers use a fluorescent compound that absorbs light energy at a specific wavelength and emits that energy at a different wavelength.

The report on E-Coli Testing Market by d users (clinical and environmental), by testing (clinical testing include (diagnostic laboratories, hospitals and other) and environmental testing include (bottled water suppliers, home & drinking water suppliers and other) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global E-Coli Testing Market is projected to grow at a CAGR between 6.0% to 6.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The global endocrine testing market was valued at US$6 billion in 2014 and is estimated to reach near about US$13 bn by 2023 at a CAGR of 8.8% from 2015 to 2023.

Immuno Oncology Assays Market

Access full Research: http://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php As per Renub Research analysis China IVD market is predicted to grow with a double digit CAGR of 19.01% in future. China IVD market is forecasted to be three times from the present market. In vitro diagnostics are playing a gradually more vital role in the provision of healthcare. About 80% of the information that physicians use to make medical decisions is produced by diagnostics and clinical laboratories. IVDs are largely used in testing, which comprises of Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug testing, HIV/AIDS and others. The Largest share of IVD products is Infectious Diseases followed by Oncology, which is the fastest growing segment mainly in the prevalence of cancer. IVD market emphasizes on Hospitals, Laboratories, Academics, the point of care testing and others are end users.

The newborn screening market was valued at USD 0.9 billion in 2021 and is expected to reach USD 1.76 billion by 2029, registering a CAGR of 8.8% during the forecast period of 2022-2029. The "immunoassays and enzymatic assays" accounts for the largest technology segment in the newborn screening market within the forecasted period owing to wide usage of these assays to screen for disorders in newborns. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Access full Research: https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. China IVD Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of chronic diseases which includes cancer, diabetes and cardiovascular disease. All of these diseases can be diagnosed and monitored using IVD products.

For more Info: https://www.renub.com/china-in-vitro-diagnostics-market-is-expected-to-grow-with-19-cagr-by-2022-32-nd.php The report China IVD Market, by Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market. The market for China In-Vitro Diagnostics (IVD) is likely to exceed US$ 12 Billion by the end of year 2024. Request a free sample copy of the report: https://www.renub.com/contactus.php

Access full Research: https://www.renub.com/cardiac-marker-analyzer-worldwide-analysis-91-p.php Global Cardiac Marker Analyzer Market is projected to cross US$ 4 Billion by the year 2024. Cardiac Marker Analyzer (Cardiac Reader Systems) offers high point of care testing results for the diagnosis of cardiac related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays. Cardiac marker analyzer efficiency and accuracy can be increased with the help of dedicated software and system which offers extensive support to diagnostic procedures and built in LCD displays for the visualization of practices.

China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease. Download Full Report: http://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php

The growing number of clinical trials and the increasing adoption of immunoassay techniques are among the primary factors driving the cancer/tumor profiling market Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/cancer-tumor-profiling-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099

The growing number of clinical trials and the increasing adoption of immunoassay techniques are among the primary factors driving the cancer/tumor profiling market. Moreover, the launch of various favorable policies by government bodies across countries for introducing numerous innovative techniques to reduce the time taken for the detection and identification of tumors is further catalyzing the market growth For an Executive Summary of Finance Cloud Report Visit the following link: https://www.imarcgroup.com/cancer-tumor-profiling-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099

The global mycoplasma testing market size reached US$ 914.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,388.2 Million by 2032, exhibiting a growth rate (CAGR) of 11.25% during 2024-2032.

Cancer Biomarkers Market Information Type (Genetic Biomarkers, Epigenetic Biomarkers, Proteomic Biomarkers, Glycoprotein Biomarkers), Disease Type, Profiling Technologies and Application: Forecast To 2027

The global E. coli testing market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.

Global Transplant Diagnostics Market size is projected to be valued $XX Billion by 2024; with a CAGR of XX% from 2017 to 2025. Transplantation is the process of relocating organ in order to treat organ failure such as

Research Beam added report on "Global and Chinese IVD Industry Development, Size, Share, Trends, Segmentation, Growth, Technology, Opportunity, Analysis and Forecast 2015" Source: http://www.researchbeam.com/report-on-global-and-chinese-ivd-industry-proposal-market

The report China In-Vitro Diagnostics Market, Forecast, Companies Analysis, Registration Rules The market for China In-Vitro Diagnostics (IVD) is likely to be thrice of its present market, growing at a CAGR of 19% by 2022. In Vitro Diagnostics (IVDs) are medical devices and accessories that are used to perform tests on the specimens taken from the human body such as blood, urine and tissue in order to treat, mitigate, monitor drug therapies, cure, or prevent illness or its abnormality. In vitro diagnostic (IVD) products are those reagents, instruments, and systems intended for use in the collection, preparation, and examination of specimens to diagnose disease or other conditions, including a decision of the state of health. For more Information: http://www.renub.com/china-in-vitro-diagnostics-market-is-expected-to-grow-with-19-cagr-by-2022-32-nd.php

The MRI systems market report analyzes the MRI systems market, the major driving forces and potential challenges that could restrict growth which is driven by developing economies and also provides comprehensive information on the key analytical content on the dynamics of the market. Browse full report @ http://bit.ly/1M3T23c

Allergy diagnostics can be segmented on the basis of the different types of product such as assay kits, consumables which comprise of the luminometers and the immunoassay analysers and many more. It helps in the identification of the nature and treatment used in allergy diagnosis. The report from IndustryARC gives an in-depth analysis and segmentation of the global allergic diagnostics market. Pricing analysis and value chain analysis will give key insights into the value addition as well as the market pricing scenario. Forecasts are provided for all the market segmentations for the period 2015 -2020. Request for TOC @ http://bit.ly/2Akq7bp

The global D-dimer testing market size was valued at US$ 1.23 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing is driving the global D-dimers market.The D-dimer test is used to find out if the patient is suffering from blood clotting disorder. The clotting of blood is very important, if the blood is not clotted, it may ooze out and the patient suffers from heavy blood loss.

The Alcohol Tests Market incorporates a vast array of products and services specifically designed for the identification and measurement of alcohol consumption in individuals. In recent times, there has been significant growth in this market, fueled by the increasing requirement for precise alcohol testing methods in diverse sectors, including law enforcement, healthcare, workplace safety, and personal usage.

There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.

Empty Capsules Market by Product (Hard gelatin, Non-gelatin capsules), Raw Material (Pig meat, Bovine, HPMC), Therapeutic Application (Antibiotics, Vitamins) & by End User (Pharmaceutical, Health Supplements) - Global Forecast to 2019

Cancer Biomarkers Market Information By Type (Genetic Biomarkers, Epigenetic Biomarkers, Proteomic Biomarkers, Glycoprotein Biomarkers), Disease Type, Profiling Technologies and Application: Forecast To 2027

Marketreportsonchina.com presents a report on “Global Proteomics Market : Company Profiles and Forecast 2015 - 2021”. http://www.marketreportsonchina.com/life-sciences-market-research-reports-18406/global-proteomics-united-states-canada-india-china-japan-united-kingdom.html Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques.

According to our new market research study titled "E. coli Testing Market –Global Analysis and Forecast – by Technology and End User," the global E. coli testing market is expected to reach US$ 2,527.73 million by 2027 from US$ 1,506.95 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The report highlights the trends prevalent in the global E. coli testing market, and the drivers and deterrents pertaining to its growth.

Immunodiagnostics market is expected to garner $17,836 Million by 2022, registering a CAGR of 7.3% during the forecast period 2016-2022. Read more at: https://www.alliedmarketresearch.com/immunodiagnostics-market The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services. The infectious diseases holds a remarkable share in the global immunodiagnostics market and is expected to maintain its lead during the study period. This is attributed by the growth in preference of automated and next generation immunodiagnostics platform due to accurate, rapid and reliable outcomes and increased adoption by the clinicians.

The global anti-venom market is primarily driven by the increasing number of deaths due to venomous bites and stings, especially in rural areas. Additionally, several favorable initiatives undertaken by the governing and non-governing agencies of various countries to spread awareness regarding snakebite envenoming and available treatment options have augmented the product demand. For an Executive Summary of Anti-Venom Report Visit the following link: https://www.imarcgroup.com/anti-venom-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099

The global market for rapid test has grown exponentially in the last few years. The market size is projected to reach USD 15.71 Billion by 2022, growing at a CAGR of around 7.7% from 2017. Emerging countries such as India, China, India, Brazil, and Argentina are the potential primary markets of the industry. Factors such as rising demand for rapid test result to enhance productivity, increasing food recalls to ensure consumer safety, stringent regulatory environment, and the emergence of new technologies are the major driving factors for this market.